Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors.

Xie, Feifan; Van Bocxlaer, Jan; Vermeulen, An

Xie, Feifan; Van Bocxlaer, Jan; Vermeulen, An.

Afiliação

Xie F; Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Van Bocxlaer J; Laboratory of Medical Biochemistry and Clinical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
Vermeulen A; Laboratory of Medical Biochemistry and Clinical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Br J Clin Pharmacol ; 87(3): 1203-1214, 2021 03.

Article em En | MEDLINE | ID: mdl-32693432

Assuntos

Inibidores da Enzima Conversora de Angiotensina; Lisinopril; Adolescente; Adulto; Criança; Pré-Escolar; Previsões; Humanos; Lactente; Modelos Biológicos

Palavras-chave

PBPK; angiotensin converting enzyme; children; lisinopril; paediatric

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Lisinopril Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google